// App-Quantinova.ai

: Polymorphisms in FcγRII (CD32) mediate abnormal antibody half-life in NOD SCID mice and reduce antibody-mediated tumour cell deletion.

Researchers

Presenter

  • Robert J Oldham

Principal Investigators

  • Kerry L Cox

  • Mark S Cragg

Medical Centers

  • Cancer Sciences, University of Southampton, Southampton, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • hCD20

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved